Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 13/20 | 0.67 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.67 |
| ▸ | ELANE | P08246 | 5/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31547371 | 1.00 | OSBP (0.67) | OSBPOSBP2ELANEPPARGPPARA | |
| Schweinfurthin B SCHEMBL847454 | 0.89 | OSBP (0.85) | OSBPOSBP2PPARGPPARA | |
| Schweinfurthin B SCHEMBL12042782 | 0.89 | OSBP (0.85) | OSBPOSBP2PPARGPPARA | |
| Schweinfurthin E SCHEMBL24867154 | 0.88 | OSBP (0.77) | OSBPOSBP2CYP19A1 | |
| SCHEMBL2608676 | 0.85 | OSBP (0.73) | OSBPOSBP2CYP19A1 | |
| SCHEMBL20003838 | 0.82 | OSBP (0.72) | OSBPOSBP2CYP19A1 | |
| Schweinfurthin A SCHEMBL20003740 | 0.80 | OSBP (1.00) | OSBPOSBP2PPARGPPARA | |
| Schweinfurthin A SCHEMBL847068 | 0.80 | OSBP (1.00) | OSBPOSBP2PPARGPPARA | |
| Schweinfurthin A SCHEMBL29378071 | 0.80 | OSBP (1.00) | OSBPOSBP2PPARGPPARA | |
| SCHEMBL30935456 | 0.79 | OSBP (0.70) | OSBPOSBP2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902228-B2 | such as: 3-Deoxyschweinfurthin B; anticancer assay; e.g. breast cancer or a cancer of the CNS or renal system diagnosis | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2011-03-08 | — | — | US | disclosed |
| US-7358377-B2 | such as: 3-Deoxyschweinfurthin B; tested and were found to have anti-cancer by NCI 60-cell line anticancer assay; e.g. breast cancer or a cancer of the CNS or renal system | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-04-15 | — | — | US | disclosed |
| US-20080015232-A1 | SCHWEINFURTHIN ANALOGUES | US GOVERNMENT - SECRETARY FOR THE ARMY | 2008-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015232-A1 | SCHWEINFURTHIN ANALOGUES | ERH, HRAS, HNRNPH1 | OSBP 2083/4885OSBP2 2163/4885ELANE 2614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.